Cholestyramine
NDC 42571-508, Cholestyramine, powder, for suspension, from Micro Labs Limited.
- Product NDC
- 42571-508
- Status
- Listed
- Labeler
- Micro Labs Limited
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219318
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42571-508 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/9g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42571-508-29 | 42571050829 | 60 POUCH in 1 CARTON (42571-508-29) / 9 g in 1 POUCH (42571-508-04) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/09420793-7357-4194-8172-0b1cddb167feNADAC price for package 42571050829
GET /v1/drugs/nadac/42571050829
Use it
Look up 42571-508 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42571-508 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42571-508. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.